A telehealth platform restructured into an MSO before its first priced round.

The company had grown across fourteen states on a structure built for a single-state pilot. Clinicians were engaged directly by the technology entity, equity had been issued informally to four early contributors, and the financial statements had never been prepared with an outside reader in mind.

A lead investor had verbally committed and set a diligence window. The founders had six weeks and no prior experience with institutional capital.

The legal restructuring and the investor materials ran as one workstream rather than in sequence, on the view that the diligence window would not survive a handoff between them.

The round closed on the original timeline. No diligence item was carried into closing as an open condition, and the regulatory structure held through a subsequent expansion into three additional states.

The company retained the firm for ongoing corporate counsel and board support.